Clinical Trial Update: 6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes [Phase 3]

View source ↗

Summary

This phase 3 trial compares morning dosing of Lantus (insulin glargine) with Neutral Protamine Hagedorn insulin (NPH) in young children with Type 1 diabetes mel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)
• Neutral Protamine Hagedorn insulin (insulin NPH)

Snippet

Sponsor: Sanofi | Conditions: Type 1 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2012-06-22